Ultrasound-Mediated Diagnosis and Therapy based on Ultrasound Contrast Agents

被引:0
|
作者
Yoon Y.I. [1 ]
Tang W. [1 ]
Chen X. [1 ]
机构
[1] Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, 20892, MD
来源
Chen, Xiaoyuan (shawn.chen@nih.gov) | 1600年 / John Wiley and Sons Inc卷 / 01期
基金
美国国家卫生研究院;
关键词
drug delivery; high-intensity focused ultrasound; microbubbles; multimodal contrast agents; ultrasound contrast agents;
D O I
10.1002/SMTD.201700173
中图分类号
学科分类号
摘要
Ultrasound-mediated diagnosis techniques have consistently attracted worldwide attention. Compared with other medical-diagnosis methods, relatively distinguished features of ultrasound being readily accessible, swift, inexpensive, and safe make it routinely used for diverse purposes. With the development of ultrasound-imaging devices, the recent advent of ultrasound contrast agents (UCAs) has expanded the sphere of ultrasound’s influence to therapy. UCAs, which are generally gas-filled and microsized bubbles, have been grafted onto multifunctional particles or molecules to selectively detect various diseases and effectively treat them. Additionally, nanosized bubbles as well as microsized bubbles have lately received a lot of attention since the phase-transition behavior of the bubbles is observed under certain conditions. The focus here is an introduction to and the preparation of therapeutic and multimodal UCAs. Also, high-intensity focused ultrasound (HIFU), among the ultrasound-mediated techniques, which enables researchers and health-care providers to overcome existing approaches, is described in depth. To close, the future and challenges of diagnosis and therapy with ultrasound are reviewed. © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
相关论文
共 50 条
  • [1] Ultrasound-Mediated Diagnosis and Therapy based on Ultrasound Contrast Agents
    Yoon, Young Il
    Tang, Wei
    Chen, Xiaoyuan
    SMALL METHODS, 2017, 1 (08):
  • [2] Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery
    Paefgen, Vera
    Doleschel, Dennis
    Kiessling, Fabian
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [3] Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities
    Pislaru, SV
    Pislaru, C
    Kinnick, RR
    Singh, R
    Gulati, R
    Greenleaf, JF
    Simari, RD
    EUROPEAN HEART JOURNAL, 2003, 24 (18) : 1690 - 1698
  • [4] Ultrasound-mediated destruction of contrast agents - Effect of ultrasound intensity, exposure, and frequency
    Walker, KW
    Pantely, GA
    Sahn, DJ
    INVESTIGATIVE RADIOLOGY, 1997, 32 (12) : 728 - 734
  • [5] Advances in Ultrasound Contrast Agents for Diagnosis & Therapy
    Kono, Y.
    Rychak, J.
    Holland, C.
    MEDICAL PHYSICS, 2015, 42 (06) : 3672 - 3672
  • [6] Properties of ultrasound contrast agents for diagnosis and therapy
    Schmitz, G
    Postema, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U1220 - U1221
  • [7] Enhancement of ultrasound-mediated fibrinolysis by platelet-targeted microbubble contrast agents.
    Suchkova, VN
    Matsunaga, TO
    Schumann, P
    Francis, CW
    BLOOD, 2001, 98 (11) : 43A - 43A
  • [8] Ultrasound-mediated ocular delivery of therapeutic agents: a review
    Lafond, Maxime
    Aptel, Florent
    Mestas, Jean-Louis
    Lafon, Cyril
    EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (04) : 539 - 550
  • [9] Ultrasound contrast agents. A new perspective in ultrasound diagnosis
    Schlief, R
    Bauer, A
    RADIOLOGE, 1996, 36 (01): : 51 - 57
  • [10] Ultrasound-mediated gene delivery: Influence of contrast agent on transfection
    Mehier-Humbert, Sophie
    Yan, Feng
    Frinking, Peter
    Schneider, Michel
    Guy, Richard H.
    Bettinger, Thierry
    BIOCONJUGATE CHEMISTRY, 2007, 18 (03) : 652 - 662